當(dāng)前位置: 首頁 » 產(chǎn)品 » 搜索

Edoxaban (tosylate monohydrate
產(chǎn)品描述：Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke preventionIC50 Value:
2015-11-06 14:35 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1176.00/10mg
010mg起訂

Edoxaban (tosylate)
產(chǎn)品描述：Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke preventionIC50 Value:
2015-11-06 14:34 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2604.00/5mg
05mg起訂

Edoxaban
產(chǎn)品描述：Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke preventionIC50 Value:
2015-11-06 14:33 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2604.00/5mg
05mg起訂

BMS-536924
產(chǎn)品描述：BMS-536924 is an ATP-competitive IGF-1R/IR inhibitor with IC50 of 100 nM/73 nM.IC50 value: 100 nM (IGF-1R); 73
2015-11-06 14:31 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1256.00/5mg
05mg起訂

Afatinib (dimaleate)
產(chǎn)品描述：Afatinib (BIBW2992) irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L858R), EGFR(L858R/T790M) and HER
2015-11-06 14:30 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

700.00/10mg
010mg起訂

Afatinib
產(chǎn)品描述：Afatinib (BIBW2992) irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L858R), EGFR(L858R/T790M) and HER
2015-11-06 14:29 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

700.00/10mg
010mg起訂

Vandetanib (hydrochloride)
產(chǎn)品描述：Vandetanib (ZD6474) is a potent inhibitor of VEGFR2 with IC50 of 40 nM.IC50 Value: 40 nM (VEGFR2) [1]Target: V
2015-11-06 14:28 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

949.00/100mg
0100mg起訂

Vandetanib (trifluoroacetate)
產(chǎn)品描述：Vandetanib (ZD6474) is a potent inhibitor of VEGFR2 with IC50 of 40 nM.IC50 Value: 40 nM (VEGFR2) [1]Target: V
2015-11-06 14:26 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2864.00/500mg
0500mg起訂

Vandetanib
產(chǎn)品描述：Vandetanib (ZD6474) is a potent inhibitor of VEGFR2 with IC50 of 40 nM.IC50 Value: 40 nM (VEGFR2) [1]Target: V
2015-11-06 14:25 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

3464.00/100mg
0100mg起訂

PD 123319 (ditrifluoroacetate
產(chǎn)品描述：PD 123319 is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM.IC50 Value: 34 nM [
2015-11-06 14:18 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

3720.00/50mg
050mg起訂

PD 123319
產(chǎn)品描述：PD 123319 is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM.IC50 Value: 34 nM [
2015-11-06 14:16 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

893.00/5mg
05mg起訂

SB 203580 (hydrochloride)
產(chǎn)品描述：SB203580(RWJ 64809) hydrochloride is a p38 MAPK inhibitor with IC50 of 0.3-0.5 uM.公司介紹：MedChemExpress(MCE
2015-11-06 14:15 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

600.00/10mg
010mg起訂

SB 203580
產(chǎn)品描述：SB203580(RWJ 64809) is a p38 MAPK inhibitor with IC50 of 0.3-0.5 uM.公司介紹：MedChemExpress(MCE)專注于各種抑
2015-11-06 14:00 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

600.00/10mg
010mg起訂

Sunitinib
產(chǎn)品描述：Sunitinib(SU-11248) is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFR with IC50 of 80 nM an
2015-11-06 13:59 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1500.00/500mg
0500mg起訂

Sunitinib (Malate)
產(chǎn)品描述：Sunitinib(SU-11248; Sutent) is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFR with IC50 of
2015-11-06 13:58 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

650.00/100mg
0100mg起訂

PD0325901
產(chǎn)品描述：PD0325901 (PD325901) is selective and non ATP-competitive MEK inhibitor with IC50 of 0.33 nM.IC50 value:Target
2015-11-06 13:57 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1125.00/10mg
010mg起訂

AG1024
產(chǎn)品描述：AG-1024 (Tyrphostin) inhibits IGF-1R autophosphorylation with IC50 of 7 M, less potent to IR with IC50 of 57 M
2015-11-06 13:56 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

884.00/5mg
05mg起訂

NVP-ADW742
產(chǎn)品描述：NVP-ADW742(ADW742; GSK 552602A ) is an selective IGF-1R inhibitor with IC50 of 0.17 M, 16-fold more potent aga
2015-11-06 13:55 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1348.00/5mg
05mg起訂

BMS-599626
產(chǎn)品描述：AC480 (BMS-599626) is a selective and efficacious inhibitor of HER1 and HER2 with IC50 of 20 nM and 30 nM, ~8-
2015-11-06 13:54 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2505.00/10mg
010mg起訂

AKT Kinase Inhibitor
產(chǎn)品描述：A Akt Kinase Inhibitor.公司介紹：MedChemExpress(MCE)專注于各種抑制劑、激動劑、API及化合物庫，總部位于美國新澤
2015-11-06 13:52 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]